MARC Record from marc_columbia

LEADER: 03093cam a2200493Ii 4500
001 14308238
005 20190923132125.0
008 190722t20192019dcua b 100 0 eng d
035 $a(OCoLC)on1109842302
040 $aNRC$beng$erda$erda$cNRC$dEEM$dOCLCO$dYDXIT$dOCLCO$dKSU$dOCLCO$dYDX$dOCLCF
019 $a1105726842$a1105956454
020 $a9780309489096$q(paperback)
020 $a0309489091$q(paperback)
035 $a(OCoLC)1109842302$z(OCoLC)1105726842$z(OCoLC)1105956454
050 04 $aQH499$b.E97 2018
060 4 $aWO 515
082 04 $a571.889$223
049 $aZCUA
111 2 $aExploring Sources of Variability Related to the Clinical Translation of Regenerative Engineering Products (Workshop)$d(2018 :$cWashington, D.C.),$jauthor.
245 10 $aExploring sources of variability related to the clinical translation of regenerative engineering products :$bproceedings of a workshop /$cMeredith Hackmann, Theresa Wizemann, and Sarah H.Beachy, rapporteurs ; Forum on Regenerative Medicine, Board on Health Sciences Policy, Health and Medicine Division, The National Academies of Sciences, Engineering, Medicine.
264 1 $aWashington, D.C. :$bNational Academies Press,$c2019.
264 4 $c©2019
300 $axx, 111 pages :$billustration ;$c23 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographic references.
505 0 $aSources of variability associated with regenerative therapies: lessons from case studies -- Factors contributing to patient variability -- Addressing variability in donor tissues and cells -- Addressing variability and meeting quality expectations in the manufacturing setting -- Exploring variability and its impact on product regulation and outcomes -- Potential next steps to consider for addressing variability.
650 0 $aRegenerative medicine.
650 0 $aTissue engineering.
650 2 $aRegenerative Medicine.$0(DNLM)D044968
650 2 $aTissue Engineering.$0(DNLM)D023822
650 7 $aRegenerative medicine.$2fast$0(OCoLC)fst01745494
650 7 $aTissue engineering.$2fast$0(OCoLC)fst01151484
655 7 $aConference papers and proceedings.$2fast$0(OCoLC)fst01423772
655 7 $aConference papers and proceedings.$2lcgft
700 1 $aHackmann, Meredith,$erapporteur.
700 1 $aWizemann, Theresa M.,$erapporteur.
700 1 $aBeachy, Sarah H.,$erapporteur.
710 2 $aNational Academies of Sciences, Engineering, and Medicine (U.S.).$bForum on Regenerative Medicine.
710 2 $aNational Academies of Sciences, Engineering, and Medicine (U.S.).$bBoard on Health Sciences Policy.
710 2 $aNational Academies of Sciences, Engineering, and Medicine (U.S.).$bHealth and Medicine Division.
776 08 $cOnline version:$tExploring sources of variability related to the clinical translation of regenerative engineering products : proceedings of a workshop.$dWashington, D.C. : National Academies Press, 2019$z0309489091$z9780309489096$w(OCoLC)1108522159
852 00 $boff,sci$hQH499$i.E97 2018g